// App-Quantinova.ai

TCT CONNECT-226 : In-Hospital Outcomes of CABG Candidates Undergoing PCI During the ICU Restricted COVID-19 Pandemic: The Multi-Center Prospective UK-REVASC Registry

Researchers

Presenter

  • Thomas Kite

Principal Investigators

  • Helen Routledge

  • Stephen Hoole

  • Nick Palmer

  • MOHANED EGRED

  • Divaka Perera

  • Kyriacos Mouyis

  • Manas Sinha

  • Luciano Candilio

  • Brijesh Anantharam

  • Aengus Murphy

  • Farzin Fath-Ordoubadi

  • Paul Das

  • Paul Morris

  • Nick Curzen

  • Diana Gorog

  • Angela Hoye

  • Charley Budgeon

  • Gregg Stone

  • Colin Berry

  • Anthony Gershlick

Medical Centers

  • North Wales Cardiac Centre, North Wales, United Kingdom

  • University of Leicester, Leicester, UNITED KINGDOM

  • University Hospital Monklands,North Lanarkshire,United Kingdom

  • Manchester Heart Centre, Mancheter, United Kingdom

  • Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.

  • Royal Free NHS Foundation Trust, London, United Kingdom

  • Barts Heart Centre, London, United Kingdom

  • St Thomas Hosp, London, United Kingdom

  • East and North Hertfordshire NHS Trust, Lister, United Kingdom

  • Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom

  • University of Western Australia, Western Australia, Australia

  • University of Sheffield, Sheffield, United Kingdom

  • Castle Hill Hosp, Kingston-upon-Hull, United Kingdom

  • Salisbury NHS Foundation Trust Hosp, Salisbury, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Mount Sinai Heart Health System, New York, New York, USA

  • Royal Papworth Hospital NHS Foundation Trust, Cambridge, England, United Kingdom

  • University Hospital Southampton, Southampton, Hampshire, United Kingdom

  • Worcester Royal Hospital, Worcester, United Kingdom

  • Golden Jubilee National Hospital, Clydebank, United Kingdom

Locations

  • United Kingdom

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Desirudin

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved